Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 401–500 of 1,001
Nucleus basalis involvement in conditioned neuronal responses in the rat frontal cortex
Rigdon, G., & Pirch, J. (1986) · The Journal of Neuroscience · doi:10.1523/jneurosci.06-09-02535.1986 · Cited by 89
Allen, S. J., Dawbarn, D., & Wilcock, G. (1988) · Brain Research · doi:10.1016/0006-8993(88)90827-x · Cited by 88
Acetylcholine-induced inhibition in the cat visual cortex is mediated by a GABAergic mechanism
Müller, C. M., & Singer, W. (1989) · Brain Research · doi:10.1016/0006-8993(89)90837-8 · Cited by 92
Aging of the serotonergic system in the rat forebrain: An immunocytochemical and neurochemical study
van Luijtelaar, M. G. P. A., Tonnaer, J. A. D. M., & Steinbusch, H. W. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90032-s · Cited by 87
Markowitsch, H. J., & Pritzel, M. (1985) · Progress in Neurobiology · doi:10.1016/0301-0082(85)90016-4 · Cited by 90
Wenk, G. L., Cribbs, B. L., & McCall, L. D. (1984) · Experimental Brain Research · doi:10.1007/bf00236289 · Cited by 87
Bhat, B. A., Almilaibary, A., Mir, R. A., Aljarallah, B. M., Mir, W. R., Ahmad, F., & Mir, M. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.884345 · Cited by 95
Bronfman, F. C., Moechars, D., & Van Leuven, F. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0283 · Cited by 87
Mandel, R. J., & Thal, L. J. (1988) · Psychopharmacology · doi:10.1007/bf00216074 · Cited by 85
Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders
Sim, T. M., Dinesh, T., Dheen, S. T., Bay, B., & Srinivasan, D. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176070 · Cited by 89
Alzheimers Disease: Interactions Between Cholinergic Functions and β- amyloid
Yan, Z., & Feng, J. (2004) · Current Alzheimer Research · doi:10.2174/1567205043331992 · Cited by 84
Härtig, W., Stieler, J., Boerema, A. S., Wolf, J., Schmidt, U., Weißfuß, J., Bullmann, T., Strijkstra, A. M., & Arendt, T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05250.x · Cited by 82
Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83
“In the brains of AD patients, the reduction of nAChRs is correlated with disease progression [161, 162], and cholinesterase inhibitors are widely used in the treatment of mild to moderate AD.”
BackgroundNeurodegeneration in Alzheimer’s disease and glaucoma: overlaps and missing links
Sen, S., Saxena, R., Tripathi, M., Vibha, D., & Dhiman, R. (2020) · Eye · doi:10.1038/s41433-020-0836-x · Cited by 84
Elshatory, Y., & Gan, L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5730-07.2008 · Cited by 82
Curcuminoids and resveratrol as anti-Alzheimer agents
Villaflores, O. B., Chen, Y.-J., Chen, C.-P., Yeh, J.-M., & Wu, T.-Y. (2012) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2012.09.005 · Cited by 77
The basal nucleus of Meynert in idiopathic Parkinson's disease
Tagliavini, F., Pilleri, G., Bouras, C., & Constantinidis, J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00798.x · Cited by 82
Sanchez‐Mejias, E., Nuñez‐Diaz, C., Sanchez‐Varo, R., Gomez‐Arboledas, A., Garcia‐Leon, J. A., Fernandez‐Valenzuela, J. J., Mejias‐Ortega, M., Trujillo‐Estrada, L., Baglietto‐Vargas, D., Moreno‐Gonzalez, I., et al. (2020) · Brain Pathology · doi:10.1111/bpa.12785 · Cited by 77
Measurement of cholinergic drug effects on memory in alzheimer's disease
Brinkman, S. D., & Gershon, S. (1983) · Neurobiology of Aging · doi:10.1016/0197-4580(83)90038-6 · Cited by 81
Loeb, C., Gandolfo, C., & Bino, G. (1988) · Stroke · doi:10.1161/01.str.19.5.560 · Cited by 81
Wood, P. L., Etienne, P. E., Lal, S., Nair, N. P. V., Finlayson, M. H., Gauthier, S. G., Palo, J., Haltia, M., Paetau, A. E., & Bird, E. D. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90200-9 · Cited by 81
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice
Perez, S. E., He, B., Muhammad, N., Oh, K.-J., Fahnestock, M., Ikonomovic, M. D., & Mufson, E. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.002 · Cited by 80
“…(CBF) projection neurons located within the septal diagonal band and the nucleus basalis of Meynert (Coyle et al., 1983; Mesulam et al., 1983; Whitehouse et al., 1981, 1985), which provide the primary cholinergic innervation to the hippocampus and the entire cortical mantle (Mesulam et al.,…”
BackgroundThe differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Wilcock, G. K., Esiri, M. M., Bowen, D. M., & Hughes, A. O. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.842 · Cited by 80
Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates
Kitt, C. A., Struble, R. G., Cork, L. C., Mobley, W. C., Walker, L. C., Joh, T. H., & Price, D. L. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90202-7 · Cited by 80
Self-citationInsights into the neuropathology of cerebral ischemia and its mechanisms
Ahad, M. A., Kumaran, K. R., Tiang, N., Mansor, N. I., Effendy, M. A., Damodaran, T. K., Lingam, K., Wahab, H. A., Nordin, N., Liao, P. H., et al. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0099 · Cited by 83
Mitochondrial biology in Alzheimer’s disease pathogenesis
Galindo, M. F., Ikuta, I., Zhu, X., Casadesus, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79
Dougherty, K. D., & Milner, T. A. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990428)407:1<77::aid-cne6>3.0.co;2-s · Cited by 78
Neural Correlates of Cognitive Impairment in Alzheimer's Disease
Van Hoesen, G. W., & Damasio, A. R. (1987) · Comprehensive Physiology · doi:10.1002/cphy.cp010522 · Cited by 80
Poon, C. H., Wang, Y., Fung, M.-L., Zhang, C., & Lim, L. W. (2020) · Aging and disease · doi:10.14336/ad.2019.1026 · Cited by 73
Nakamura, S., & Vincent, S. R. (1986) · Brain Research · doi:10.1016/0006-8993(86)91099-1 · Cited by 80
Leventer, S. M., McKeag, D. W., CLANCY, M., Wülfert, E., & Hanin, I. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90031-0 · Cited by 78
Subset of neurons characterized by the presence of NADPH‐diaphorase in human substantia innominata
Ellison, D. W., Kowall, N. W., & Martin, J. B. (1987) · The Journal of Comparative Neurology · doi:10.1002/cne.902600207 · Cited by 83
Christensen, D. Z., Bayer, T. A., & Wirths, O. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.022 · Cited by 77
Garabadu, D., & Verma, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.04.006 · Cited by 75
Current Therapeutic Options for Alzheimers Disease
Lleo, A. (2007) · Current Genomics · doi:10.2174/138920207783769549 · Cited by 76
Rupp, N. J., Wegenast‐Braun, B. M., Radde, R., Calhoun, M. E., & Jucker, M. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.014 · Cited by 94
Alzheimer's Disease as a Capillary Dementia
Scheibel, A. B., Duong, T., & Jacobs, R. (1989) · Annals of Medicine · doi:10.3109/07853898909149194 · Cited by 77
Tiseo, Perdomo, & Friedhoff (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.0460s1025.x · Cited by 76
Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease
Bennett, M. C., Diamond, D. M., Stryker, S. L., Parks, J. K., & Parker, W. D. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500206 · Cited by 77
Magnetic resonance imaging of Alzheimer’s disease
Lehéricy, S., Marjańska, M., Mesrob, L., Sarazin, M., & Kinkingnéhun, S. (2006) · European Radiology · doi:10.1007/s00330-006-0341-z · Cited by 82
Pathologic Changes in the Olfactory System in Aging and Alzheimer's Diseasea
Hyman, B. T., Arriagada, P. V., & Hoesen, G. W. V. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00184.x · Cited by 78
Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease
Thal, L. J., Masur, D. M., Sharpless, N. S., Fuld, P. A., & Davies, P. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90032-1 · Cited by 76
A comparison of the effects of two inhibitors on brain cholinesterase
Hallak, M. E., & Giacobini, E. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90143-2 · Cited by 76
Choline acetyltransferase: Purification and immunohistochemical localization
McGeer, P. L., McGeer, E. G., & Peng, J. H. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90419-3 · Cited by 80
Magnetoencephalography as a Putative Biomarker for Alzheimer′s Disease
ZAMRINI, E. Y., Maestú, F., Pekkonen, E., Funke, M. E., Mäkelä, J. P., Riley, M., Bajo, R., Sudre, G. P., Fernández, A., Castellanos, N. P., et al. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/280289 · Cited by 79
Alzheimer disease: Plaques, tangles, and the basal forebrain
Whitehouse, P. J., Struble, R. G., Clark, A. W., & Price, D. L. (1982) · Annals of Neurology · doi:10.1002/ana.410120517 · Cited by 75
Self-citationNakamura, S., Takemura, M., Ohnishi, K., Suenaga, T., Nishimura, M., Akiguchi, I., Kimura, J., & Kimura, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90019-h · Cited by 75
Altman, H. J., Crosland, R. D., Jenden, D. J., & Berman, R. F. (1985) · Neurobiology of Aging · doi:10.1016/0197-4580(85)90030-2 · Cited by 75
Ehrenberg, A. J., Kelberman, M. A., Liu, K. Y., Dahl, M. J., Weinshenker, D., Falgàs, N., Dutt, S., Mather, M., Ludwig, M., Betts, M. J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12937 · Cited by 74
Mansouri, A., Haouzi, D., Descatoire, V., Demeilliers, C., Sutton, A., Vadrot, N., Fromenty, B., Feldmann, G., Pessayre, D., & Berson, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50353 · Cited by 73
Funkenstein, H. H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540010045016 · Cited by 75
Aigner, T. G., Mitchell, S. J., Aggleton, J. P., DeLong, M. R., Struble, R. G., Price, D. L., Wenk, G. L., Pettigrew, K. D., & Mishkin, M. (1991) · Experimental Brain Research · doi:10.1007/bf00231036 · Cited by 77
Self-citationPreferential Cerebrospinal Fluid Acetylcholinesterase Inhibition by Rivastigmine in Humans
Kennedy, J. S., Polinsky, R. J., Johnson, B., Loosen, P., Enz, A., Laplanche, R., Schmidt, D., Mancione, L. C., Parris, W. C. V., & Ebert, M. H. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199912000-00005 · Cited by 73
Potential Role of Muscarinic Agonists in Alzheimerʼs Disease
Avery, E., Baker, L. D., & Asthana, S. (1997) · Drugs & Aging · doi:10.2165/00002512-199711060-00004 · Cited by 77
Shimohama, S., Taniguchi, T., Fujiwara, M., & Kameyama, M. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00753.x · Cited by 73
Vesicular neurotransmitter transporters: Potential sites for the regulation of synaptic function
Varoqui, H., & Erickson, J. D. (1997) · Molecular Neurobiology · doi:10.1007/bf02740633 · Cited by 82
Liskowsky, W., & Schliebs, R. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.010 · Cited by 73
Dickinson, B. A., Jo, J., Seok, H., Son, G. H., Whitcomb, D. J., Davies, C. H., Sheng, M., Collingridge, G. L., & Cho, K. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-18 · Cited by 71
Wiley, R. G., Berbos, T. G., Deckwerth, T. L., Johnson, E. M., & Lappi, D. A. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00226-e · Cited by 73
Luo, Y., Sun, Y., Tian, X., Zheng, X., Wang, X., Li, W., Wu, X., Shu, B., & Hou, W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.619543 · Cited by 64
Muthuraju, S., Maiti, P., Solanki, P., Sharma, A. K., Amitabh, Singh, S. B., Prasad, D. N., & Ilavazhagan, G. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.026 · Cited by 81
RetractedSanchez-Espinosa, M. P., Atienza, M., & Cantero, J. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.027 · Cited by 82
Satoh, A., & Iijima, K. M. (2019) · Brain Research · doi:10.1016/j.brainres.2017.12.027 · Cited by 68
Selective vulnerability in Alzheimer's disease: Amyloid precursor protein and p75NTR interaction
Fombonne, J., Rabizadeh, S., Banwait, S., Mehlen, P., & Bredesen, D. E. (2009) · Annals of Neurology · doi:10.1002/ana.21578 · Cited by 69
Sultana, R., Perluigi, M., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 80
Turner, M. A., Moran, N. F., & Kopelman, M. D. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.2.148 · Cited by 72
A 24-week randomized trial of controlled-release physostigmine in patients with Alzheimer’s disease
Thal, L. J., Ferguson, J. M., Mintzer, J., Raskin, A., & Targum, S. D. (1999) · Neurology · doi:10.1212/wnl.52.6.1146 · Cited by 74
Wada, Y., Nanbu, Y., Kikuchi, M., Koshino, Y., Hashimoto, T., & Yamaguchi, N. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050038 · Cited by 71
Cholinergic receptors in aging and Alzheimer's disease
Whitehouse, P. J., & Au, K. S. (1986) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(86)90035-7 · Cited by 72
Self-citationSelective attention in Alzheimer's disease: Characterizing cognitive subgroups of patients
Freed, D. M., Corkin, S., Growdon, J. H., & Nissen, M. J. (1989) · Neuropsychologia · doi:10.1016/0028-3932(89)90022-5 · Cited by 71
Kolisnyk, B., Al-Onaizi, M. A., Hirata, P. H. F., Guzman, M. S., Nikolova, S., Barbash, S., Soreq, H., Bartha, R., Prado, M. A. M., & Prado, V. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1933-13.2013 · Cited by 67
CHOLINERGIC DEFICIT IN FRONTAL CEREBRAL CORTEX IN ALZHEIMER'S DISEASE IS AGE DEPENDENT
Rossor, M. N., Iversen, L. L., Johnson, A. L., Mountjoy, C. Q., & Roth, M. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92836-1 · Cited by 70
Ransmayr, G. N., Cervera, P., Hirsch, É. C., Ruberg, M., Hersh, L. B., Duyckaerts, C. J., Hauw, J., Delumeau, C., & Agid, Y. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90291-1 · Cited by 70
Pathological Aging of the Brain: An Overview
Bastos Leite, A. J., Scheltens, P., & Barkhof, F. (2004) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000168070.90113.dc · Cited by 68
NGF mRNA is not decreased in frontal cortex from Alzheimer's Disease patients
Jetté, N., Cole, M., & Fahnestock, M. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90159-7 · Cited by 74
Nickell, W. T., & Shipley, M. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-12-04492.1988 · Cited by 74
Pharmacological manipulations of the substantia innominata-cortical cholinergic pathway
Wenk, G. L. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90269-6 · Cited by 69
Kristt, D. A., McGowan, R. A., Martin-MacKinnon, N., & Solomon, J. (1985) · Brain Research · doi:10.1016/0006-8993(85)91606-3 · Cited by 69
Coma and Related Global Disturbances of the Human Conscious State
Plum, F. (1991) · Cerebral Cortex · doi:10.1007/978-1-4615-6622-9_9 · Cited by 68
Developmental specification of forebrain cholinergic neurons
Allaway, K. C., & Machold, R. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2016.11.007 · Cited by 68
Four Decades of Neurodegenerative Disease Research: How Far We Have Come!
Young, A. B. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3767-09.2009 · Cited by 72
An update on huperzine A as a treatment for Alzheimer's disease
Little, J. T., Walsh, S. P., & Aisen, P. S. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.209 · Cited by 73
Katsouri, L., Vizcaychipi, M. P., McArthur, S., Harrison, I. F., Suárez‐Calvet, M., Lleó, A., Lloyd, D. G., Ma, D., & Sastre, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.010 · Cited by 73
Ashford, J. W. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150381 · Cited by 68
Chen, X.-Q., Sawa, M., & Mobley, W. C. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.341 · Cited by 65
RETT SYNDROME: NEUROBIOLOGICAL CHANGES UNDERLYING SPECIFIC SYMPTOMS
Wenk, G. L. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(96)00059-7 · Cited by 71
Hippocampal choline acetyltransferase activity correlates with spatial learning in aged rats
Dunbar, G. L., Rylett, R. J., Schmidt, B. M., Sinclair, R. C., & Williams, L. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90378-z · Cited by 71
Nyakas, C. J., Oosterink, B. J., Keijser, J. N., Felszeghy, K., de Jong, G. I., Korf, J., & Luiten, P. G. M. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00025-2 · Cited by 68
Alzheimer's disease: neuropathological correlates of cognitive and motor disorders
Mölsä, P. K., Säkö, E., Paljärvi, L., Rinne, J. O., & Rinne, U. K. (1987) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1987.tb05465.x · Cited by 68
Asanuma, M., Nishibayashi, S., Iwata, E., Kondo, Y., Nakanishi, T., Gómez‐Vargas, M., & Ogawa, N. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00098-8 · Cited by 67
Tabaton, M., Schenone, A. E., Romagnoli, P., & Mancardi, G. (1985) · Acta Neuropathologica · doi:10.1007/bf00690198 · Cited by 67
Siˇmić, G., Mrzljak, L., Fucic, A., Winblad, B. G., Lovrić, H., & Kostović, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00304-2 · Cited by 69
Ebert, U., Grossmann, M., Oertel, R., Gramatté, T., & Kirch, W. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122009836 · Cited by 63
Imaging Alzheimer's disease: clinical applications
Minoshima, S. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00099-6 · Cited by 69
Iqbal, D., Rehman, M. T., Dukhyil, A. B., Rizvi, S. M. D., Ajmi, M. F. A., Alshehri, B., Banawas, S., Khan, M. S., Alturaiki, W., & Alsaweed, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090937 · Cited by 67
Patel, A. V., Yamashita, N., Ascaño, M., Bodmer, D., Boehm, E. D., Bodkin-Clarke, C., Ryu, Y. K., & Kuruvilla, R. (2015) · Nature Communications · doi:10.1038/ncomms10119 · Cited by 67
Shang, J., Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., & Abe, K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151126 · Cited by 63
HDAC 2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease
Mahady, L., Nadeem, M., Malek‐Ahmadi, M., Chen, K., Perez, S. E., & Mufson, E. J. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12518 · Cited by 63
Sánchez, D., Castilla-Marti, M., Rodríguez‐Gómez, O., Valero, S., Piferrer, A., Martínez, G., Martínez, J., Serra, J., Moreno–Grau, S., Hernández‐Olasagarre, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34577-3 · Cited by 69
Cantero, J. L., Atienza, M., Lage, C., Záborszky, L., Vilaplana, E., López‐García, S., Pozueta, A., Rodríguez‐Rodríguez, E., Blesa, R., Alcolea, D. A., et al. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz224 · Cited by 66
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.